Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 3Substance-Related Disorders 1Smoking Cessation 1Head and Neck Neoplasms 1

Interventions

Ultrasonic Waves 1Tobacco Use Cessation Devices 1Nicotine Replacement Therapy 1Nicotine Chewing Gum 1Ethanol 1Educational Status 1Acceptance and Commitment Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Substance-Related Disorders × Acceptance and Commitment Therapy × 90 days × Clear all
NCT05643027 2026-05-14

ACTION

Dana-Farber Cancer Institute

Phase NA Completed
40 enrolled

Neoplasms, Substance-Related Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡